Cyclosporin A-Derivative 1 (Free base) is a crystalline intermediate derived from the opening of cyclosporin A extracted from patent WO 2013167703 A1. Cyclosporin A is an immunosuppressive agent which can bind to the cyclophilin and inhibit calcineurin.
Cyclosporin A-Derivative 1 Free base is a chemically modified analog of the well-known cyclic peptide cyclosporin A, distinguished by specific alterations to its molecular structure that confer unique biochemical properties. As a member of the cyclic peptide family, this derivative maintains the core macrocyclic framework while introducing modifications that can influence its interaction with protein targets and cellular pathways. Its structure-function relationship makes it a valuable tool for probing peptide-protein interactions, conformational dynamics, and the role of specific functional groups in biological activity. Researchers utilize such derivatives to dissect complex biochemical mechanisms, explore structure-activity relationships, and develop novel modulators for a variety of cellular processes.
Peptide-protein interaction studies: Cyclic peptides like this derivative are frequently employed in the investigation of protein binding events, particularly those involving immunophilins such as cyclophilins and related peptidyl-prolyl isomerases. The unique side-chain modifications present in Cyclosporin A-Derivative 1 Free base enable researchers to analyze how structural changes impact binding affinity, selectivity, and downstream signaling. By comparing the interaction profiles of the parent compound and its derivatives, scientists gain deeper insight into the determinants of protein recognition and allosteric modulation.
Signal transduction research: Due to its structural resemblance to cyclosporin A, this derivative is often used to study intracellular signaling pathways regulated by cyclic peptides. Its ability to modulate specific protein-protein interactions makes it a valuable probe for dissecting pathways such as calcineurin-dependent signaling cascades. By introducing this compound into cellular models, researchers can selectively perturb signaling events, enabling the elucidation of key regulatory nodes and feedback mechanisms within the cell.
Peptide synthesis and design: The free base form of Cyclosporin A-Derivative 1 is particularly advantageous in synthetic peptide chemistry. It serves as a reference scaffold for the development of novel cyclic peptide libraries, providing a template for the systematic modification of amino acid residues and side chains. This facilitates the rational design of peptides with improved stability, target specificity, or membrane permeability, supporting the advancement of peptide-based research tools and molecular probes.
Conformational analysis: The macrocyclic structure and unique substitutions of this derivative make it an excellent model for studying peptide folding and conformational preferences. Using techniques such as NMR spectroscopy, X-ray crystallography, or computational modeling, scientists can investigate how specific modifications influence the overall shape, dynamics, and intramolecular interactions of cyclic peptides. These studies contribute to a broader understanding of peptide structural biology and inform the design of next-generation bioactive molecules.
Analytical method development: The compound's distinctive physicochemical characteristics also render it useful in the development and validation of analytical techniques for cyclic peptides. It serves as a benchmark molecule for optimizing chromatographic separation, mass spectrometric detection, and quantitative analysis protocols. By leveraging its well-defined structure and known properties, laboratories can establish robust methods for the identification and characterization of related peptide compounds in complex mixtures, improving the accuracy and reliability of peptide analytics in research settings.
1. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
2. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
3. Cationic cell-penetrating peptides are potent furin inhibitors
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More